Effectiveness of Rosuvastatin at Preventing the Progression of Atherosclerosis in HIV Positive Patients

NCT00673582 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

250

Enrollment

OTHER

Sponsor class

Stopped Sponsor has withdrawn the funding

Conditions

Atherosclerosis
HIV Infections

Interventions

DRUG: Rosuvastatin
DRUG: Placebo

Sponsor

University of British Columbia

Collaborators

[object Object]
[object Object]